Ausgabe 5/2018
Inhalt (13 Artikel)
Current drug therapy for heart failure with reduced ejection fraction
D. Berliner, M. Hallbaum, J. Bauersachs
Heart failure with mid-range ejection fraction and with preserved ejection fraction
J. Petutschnigg, F. Edelmann
Ventricular assist device therapy and heart transplantation: Benefits, drawbacks, and outlook
S. Buchholz, S. P. W. Guenther, S. Michel, R. Schramm, C. Hagl
Device therapy in heart failure with reduced ejection fraction—cardiac resynchronization therapy and more
D. Duncker, C. Veltmann
Treatment options in myocarditis and inflammatory cardiomyopathy
B. Maisch, P. Alter
Interatrial septum versus right atrial appendage pacing for prevention of atrial fibrillation
L. Zhang, H. Jiang, W. Wang, J. Bai, Y. Liang, Y. Su, J. Ge
Outcomes of direct stenting in patients with ST-elevated myocardial infarction
A. Kalayci, V. Oduncu, C. Y. Karabay, A. Erkol, A. C. Tanalp, I. H. Tanboga, O. Candan, C. Gecmen, I. A. Izgi, C. Kirma
Association of soluble ST2 with functional capacity in outpatients with heart failure
O. Yucel, I. Gul, A. Zararsiz, O. Demirpence, H. Yucel, Z. Cinar, A. Zorlu, M. B. Yilmaz
Relationship between inducible NOS single-nucleotide polymorphisms and hypertension in Han Chinese
Z. Zhai, Z. Wang, L. Wang, S. Chen, H. Ren, D. Wang
Comorbidity, chronic obstructive pulmonary disease, and acute cardiovascular diseases
K. Papastergiou, K. Gourgoulianis
Essenzielle kardiale Biomarker in der Differenzialdiagnose des akuten Thoraxschmerzes
M. Vafaie, E. Giannitsis, H. A. Katus